Journal profile · CELL BIOLOGY-ENGINEERING, BIOMEDICAL
Cell and Tissue Banking
ISSN 1389-9333 · eISSN 1573-6814 · Springer Netherlands · NETHERLANDS · Quarterly · Founded 2000
Cell and Tissue Banking: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.26; hybrid open access; APC about USD 3,990; median 163 days to acceptance (97 articles, last 24 months); community-reported acceptance: easy; 51 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cell and Tissue Banking is published by Springer Netherlands and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Tissue Engineering and Regenerative Medicine, Mesenchymal stem cell research and Corneal Surgery and Treatments, together about 23.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Cell and Tissue Banking (CATB) provides a forum for disseminating information to scientists and clinicians involved in the banking and transplantation of cells and tissues. Cell and Tissue Banking is an international, peer-reviewed sound science journal that publishes original papers in the following areas: basic research concerning general aspects of tissue banking, including but not limited to: quality assurance and control of banked cells/tissues effects of preservation and sterilisation methods of cells/tissues biotechnology clinical applications of banked cells/tissues standards of practice in procurement, processing, storage and distribution of cells/tissues ethical issues medico-legal issues As a sound science journal, CATB's editorial assessment does not focus on the extent of the advances reported or the novelty of submitted papers. All valid and scientifically sound research which is within scope for the journal will be considered.
From the journal's Aims & Scope
Research area (LetPub): CELL BIOLOGY-ENGINEERING, BIOMEDICAL
Editor-in-chief Diletta TrojanPublisher website
Editorial board by country: none in mainland China; most named United States 5, India 5, Italy 5, United Kingdom 3, Spain 3 (54 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Tissue Engineering and Regenerative MedicineMedicine8%
- Mesenchymal stem cell researchMedicine7.9%
- Corneal Surgery and TreatmentsMedicine7.7%
- Periodontal Regeneration and TreatmentsMedicine5.9%
- Orthopaedic implants and arthroplastyMedicine5.6%
- Bone Tissue Engineering MaterialsEngineering5.6%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science5%
- Wound Healing and TreatmentsMedicine5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Engineering, Biomedical | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Engineering, Biomedical | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Engineering, Biomedical | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINECASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.26LetPub ·
- Impact factor (publisher) 2025
- 2.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 2Publisher website ·
- CiteScore 2026-06
- 4.7LetPub ·
- SJR 2026-06
- 0.55LetPub ·
- SNIP 2026-06
- 0.75LetPub ·
- h-index
- 40LetPub ·
- h-index
- 63OpenAlex ·
- i10-index
- 684OpenAlex ·
- 2-year mean citedness
- 1.93OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 24.24%LetPub ·
Volume
- Articles per year
- 46LetPub ·
- Downloads per year (publisher) 2025
- 190,100Publisher website ·
Articles by year OpenAlex count · 1,567 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 48 | 16 | 12 |
| 2025 | 51 | 13 | 79 |
| 2024 | 35 | 12 | 167 |
| 2023 | 56 | 20 | 339 |
| 2022 | 83 | 22 | 699 |
| 2021 | 96 | 33 | 927 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
163 daysMedian, submission to acceptance · P25–P75 95 days – 269 days
- Acceptance to online
- median 21 days (97 articles)
- Submission to online
- median 188 days
- Sample
- 97 articles with submission and acceptance dates (100 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,990 / EUR 2,990 / GBP 2,590 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Author–date
- Suggested reviewers
- Optional
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Trial registration / reporting guidelines
- AI use Generative AI Images
AI/LLM use policy Model summary
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
Competing interests disclosure required Model summary
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
Data transparency policy Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
Animal research guidelines Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Cell and Tissue Banking, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Reviewer suggestion allowed Model summary
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts.
Source ↗Publisher website ·- Plagiarism
Originality and plagiarism policy Model summary
The manuscript should not be submitted to more than one journal for simultaneous consideration.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Netherlands
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Quarterly
- Founded
- 2000
- ISSN
- 1389-9333
- Electronic ISSN
- 1573-6814
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Cell and Tissue Banking
What CAS zone is Cell and Tissue Banking in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cell and Tissue Banking is in Zone 4 of Medicine, and in Zone 4 of the minor category Cell Biology / Engineering, Biomedical. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cell and Tissue Banking?
The latest impact factor listed by LetPub is 2.26; CiteScore 4.7, h-index 63.
How long does peer review take at Cell and Tissue Banking?
Based on the dates recorded on 97 articles published between September 2024 and September 2026 (the last 24 months), the median time from submission to acceptance is 163 days (interquartile range 95–269 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Cell and Tissue Banking?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Author–date; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Cell and Tissue Banking based?
Of the 54 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (5), India (5) and Italy (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Cell and Tissue Banking?
According to LetPub and DOAJ records, Cell and Tissue Banking is indexed in SCIE and Scopus. The journal's website also lists MEDLINE and CAS; that list has not been checked against each database.
Is Cell and Tissue Banking open access, and what is the APC?
Cell and Tissue Banking is a hybrid journal. For open-access publication: APC about USD 3,990.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .